Global Diagnostic Testing of STDs Market Overview And Scope:
Global Diagnostic Testing of STDs Market Size was estimated at USD 96757.37 million in 2022 and is projected to reach USD 127063.21 million by 2028, exhibiting a CAGR of 4.65% during the forecast period.
The Global Diagnostic Testing of STDs Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Diagnostic Testing of STDs utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Roche, Abbott, Becton Dickinson, BioMerieux, Danaher, Hologic
Global Diagnostic Testing of STDs Market Segmentation
By Type, Diagnostic Testing of STDs market has been segmented into:Chlamydia testing
Gonorrhea testing
PandS Syphilis testing
HPV testing
HSV testing
HIV testing
Chancroid testing
By Application, Diagnostic Testing of STDs market has been segmented into:
Hospitals
Clinics
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Diagnostic Testing of STDs market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Diagnostic Testing of STDs market.
Top Key Players Covered in Diagnostic Testing of STDs market are:
Roche
Abbott
Becton Dickinson
BioMerieux
Danaher
Hologic
Objective to buy this Report:
1. Diagnostic Testing of STDs analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Diagnostic Testing of STDs market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Diagnostic Testing of STDs Market by Type
5.1 Diagnostic Testing of STDs Market Overview Snapshot and Growth Engine
5.2 Diagnostic Testing of STDs Market Overview
5.3 Chlamydia testing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Chlamydia testing: Geographic Segmentation
5.4 Gonorrhea testing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Gonorrhea testing: Geographic Segmentation
5.5 PandS Syphilis testing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 PandS Syphilis testing: Geographic Segmentation
5.6 HPV testing
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 HPV testing: Geographic Segmentation
5.7 HSV testing
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 HSV testing: Geographic Segmentation
5.8 HIV testing
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 HIV testing: Geographic Segmentation
5.9 Chancroid testing
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Chancroid testing: Geographic Segmentation
Chapter 6: Diagnostic Testing of STDs Market by Application
6.1 Diagnostic Testing of STDs Market Overview Snapshot and Growth Engine
6.2 Diagnostic Testing of STDs Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinics: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Diagnostic Testing of STDs Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Diagnostic Testing of STDs Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Diagnostic Testing of STDs Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ROCHE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ABBOTT
7.4 BECTON DICKINSON
7.5 BIOMERIEUX
7.6 DANAHER
7.7 HOLOGIC
Chapter 8: Global Diagnostic Testing of STDs Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Chlamydia testing
8.2.2 Gonorrhea testing
8.2.3 PandS Syphilis testing
8.2.4 HPV testing
8.2.5 HSV testing
8.2.6 HIV testing
8.2.7 Chancroid testing
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Clinics
Chapter 9: North America Diagnostic Testing of STDs Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Chlamydia testing
9.4.2 Gonorrhea testing
9.4.3 PandS Syphilis testing
9.4.4 HPV testing
9.4.5 HSV testing
9.4.6 HIV testing
9.4.7 Chancroid testing
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Clinics
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Diagnostic Testing of STDs Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Chlamydia testing
10.4.2 Gonorrhea testing
10.4.3 PandS Syphilis testing
10.4.4 HPV testing
10.4.5 HSV testing
10.4.6 HIV testing
10.4.7 Chancroid testing
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Clinics
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Diagnostic Testing of STDs Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Chlamydia testing
11.4.2 Gonorrhea testing
11.4.3 PandS Syphilis testing
11.4.4 HPV testing
11.4.5 HSV testing
11.4.6 HIV testing
11.4.7 Chancroid testing
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Clinics
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Diagnostic Testing of STDs Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Chlamydia testing
12.4.2 Gonorrhea testing
12.4.3 PandS Syphilis testing
12.4.4 HPV testing
12.4.5 HSV testing
12.4.6 HIV testing
12.4.7 Chancroid testing
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Clinics
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Diagnostic Testing of STDs Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Chlamydia testing
13.4.2 Gonorrhea testing
13.4.3 PandS Syphilis testing
13.4.4 HPV testing
13.4.5 HSV testing
13.4.6 HIV testing
13.4.7 Chancroid testing
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Clinics
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Diagnostic Testing of STDs Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Chlamydia testing
14.4.2 Gonorrhea testing
14.4.3 PandS Syphilis testing
14.4.4 HPV testing
14.4.5 HSV testing
14.4.6 HIV testing
14.4.7 Chancroid testing
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals
14.5.2 Clinics
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Diagnostic Testing of STDs Scope:
|
Report Data
|
Diagnostic Testing of STDs Market
|
|
Diagnostic Testing of STDs Market Size in 2025
|
USD XX million
|
|
Diagnostic Testing of STDs CAGR 2025 - 2032
|
XX%
|
|
Diagnostic Testing of STDs Base Year
|
2024
|
|
Diagnostic Testing of STDs Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Roche, Abbott, Becton Dickinson, BioMerieux, Danaher, Hologic.
|
|
Key Segments
|
By Type
Chlamydia testing
Gonorrhea testing
PandS Syphilis testing
HPV testing
HSV testing
HIV testing
Chancroid testing
By Applications
Hospitals
Clinics
|
